Kirstein Business Library & Innovation Center

Lower Level, Johnson Building, Central Library, 617 536-5400,

Food and Drug Administration Approves Biogen Idec Hemophilia Drug

by blippmeier

biogen idecTwo months after the Food and Drug Administration approved the first new hemophilia treatment in 17 years, its maker, Biogen Idec Inc., got approval on June 6 to market a drug that controls and prevents bleeding in adults and children with the most common form of the disease, hemophilia A.

An estimated 16,000 people in the United States have hemophilia A. This inherited disorder prevents normal blood clotting in patients, leading to repeated and extended bleeding that can cause pain and joint damage.For more on Biogen Idec, try Business and Industry or Business Insights: Essentials , available to Massachusetts residents with a Metro Boston Library Network card or an eCard.


Leave a Reply

Please remember the commenting guidelines:
  1. No spam, personal attacks, or rudeness.
  2. Stay on topic.